TTY Biopharm Company Limited (TPEX:4105)

TTY Biopharm Company Revenue

In the year 2025, TTY Biopharm Company had annual revenue of 6.45B TWD with 9.49% growth. TTY Biopharm Company had revenue of 1.66B in the quarter ending December 31, 2025, a decrease of -2.92%.

• Revenue: 6.45B
• Revenue Growth: +9.49%
• P/S Ratio: 2.87
• Revenue / Employee: 18.87M
• Employees: 342
• Market Cap: 18.50B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.45B	559.10M	9.49%
Dec 31, 2024	5.89B	388.31M	7.05%
Dec 31, 2023	5.51B	443.94M	8.77%
Dec 31, 2022	5.06B	526.00M	11.60%
Dec 31, 2021	4.54B	313.77M	7.43%